Sientra collapse doomed execs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dignity Health investment in Central Coast paying off
During the past five years, Dignity Health has made methodical moves to bolster the healthcare system in North Santa Barbara and San Luis Obispo counties. That strategy has paid off in improved patient care and better facilities. Now health care is emerging as an industry that attracts talent and capital. It’s an industry that has Read More →
Corporate social responsibility on hold when it comes to outrageous drug prices
Imagine you just went to your local pharmacy and were told that the cost of a life-saving drug was $22,500 for 30 tablets to treat AIDS or another infectious disease. Well, if you need the drug Daraprim, that is what you would have to pay. Turing Pharmaceuticals purchased the right to Darprim this past August Read More →
European regulators approve Amgen cancer drug Kyprolis
Thousand Oaks-based Amgen scored another major victory Nov. 19. European regulators approved experimental drug Kyprolis on Thursday for patients who have received at least one prior treatment for multiple-myeloma. Kyprolis was the cornerstone of Amgen’s $10.4 billion buyout of Onyx Pharmaceuticals in 2013. Multiple-myeloma is a form of blood cancer that forms in plasma cells Read More →
French Hospital Medical Center unveils educational facility
French Hospital Medical Center has taken the wraps off an 18,000-square-foot health and education facility it hopes will forge closer ties between the hospital and higher education in San Luis Obispo. With about 200 business and community leaders standing by, CEO Alan Iftinik unveiled the Copeland Health Education Pavilion. Iftinik said the building, which Read More →
Goleta-based Sientra’s third quarter revenues down
Sientra Inc. sales were down 6.9 percent in the third quarter of 2015 but the results were largely unaffected by recent pandemonium at the company. The Goleta-based company reported third quarter results on Nov. 16 for the quarter that ended on Sept. 30, just one week after European regulators pulled products made by Sientra’s Brazilian Read More →
